[1] Chaudhary S, Bhatta NK, Lamsal M, et al.Serum procalcitonin in bacterial & non-bacterial meningitis in children[J]. BMC Pediatr, 2018, 18(1): 342. [2] Choi JJ, McCarthy MW. Novel applications for serum procalcitonin testing in clinical practice[J]. Expert Rev Mol Diagn, 2018, 18(1): 27-34. [3] Fakheri RJ.Can procalcitonin guide decisions about antibiotic management?[J]. Cleve Clin J Med, 2019, 86(5):307-311. [4] 降钙素原急诊临床应用专家共识组.降钙素原(PCT)急诊临床应用的专家共识[J].中华急诊医学杂志,2012,21(9):944-951. [5] 中国医师协会急诊医师分会,中国研究型医院学会休克与脓毒症专业委员会.中国脓毒症/脓毒性休克急诊治疗指南(2018)[J]. 感染、炎症、修复,2019,3(20):3-20. [6] Waterfield T, Maney JA, Hanna M, et al.Point-of-care testing for procalcitonin in identifying bacterial infections in young infants: a diagnostic accuracy study[J]. BMC Pediatr, 2018, 18(1): 387. [7] Pfäfflin A, Schleicher E.Inflammation markers in point-of-care testing (POCT)[J]. Anal Bioanal Chem, 2009, 393(5): 1473-1480. [8] 吴文娟. 感染性疾病现场快速检验技术的现状与未来[J].中华检验医学杂志,2018,41(9):641-643. [9] 孙胜男,吕菁君,魏捷.脓毒症患者降钙素原浓度与病原学感染证据之间的相关性研究[J].中华急诊医学杂志,2013,22(10):1136-1141. [10] Kade G,Literacki S, Rzeszotarska A,et al.Removal of procalcitonin and selected cytokines during continuous venovenous hemodialysis using high cutoff hemofilters in patients with sepsis and acute kidney injury[J]. Blood Purif, 2018, 46(2): 153-159. [11] 王彬,岳化葵,熊玮,等. POCT 检测肌红蛋白对心肌梗死的诊断价值[J]. 检验医学与临床,2018,15(5):722-724. [12] Kankaanpää M, Holma-Eriksson M, Kapanen S, et al.Comparison of the use of comprehensive point-of-care test panel to conventional laboratory process in emergency department[J]. BMC Emerg Med, 2018, 18(1): 43. [13] 胥国强,康清秀,李文楷,等. 5种床旁检测法与Abbott化学发光法检测心肌标志物的对比研究[J]. 四川医学,2018,39(2):157-160. [14] Aldabbagh S, Marx B, Eis-Hübinger AM, et al.Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity[J]. Public Health, 2020, 182: 170-172. [15] 朱蕾,韩冰,杜光艳. POCT与STAR在凝血检验和肝素治疗监测中的应用分析[J]. 标记免疫分析与临床,2015,7(22):706-707. [16] 鲁礡. 全自动POCT 免疫定量分析系统检测降钙素原与罗氏电化学发光可比性研究[J]. 系统医学,2017,11(2):39-41. [17] Musaad SM,Khan SA,Herd G.Point-of-care testing: High time for a dedicated National Adverse Event Monitoring System[J]. Clin Biochem Rev,2015,36(1): 3. [18] Huddy JR, Ni MZ,Markar SR, et al.Point-of-care testing in the diagnosis of gastrointestinal cancers: Current technology and future directions[J]. World J Gastroenterol,2015,21(14): 411. [19] Kitchen DP, Jennings I, Kitchen S, et al.Bridging the gap between point-of-care testing and laboratory testing in hemostasis[J]. Semin Thromb Hemost, 2015, 41(3): 272-278. |